Unknown PHASE2 INTERVENTIONAL 4-arm NCT03471455

Isotretinoin In Preventing Recurrences In Chronic Recurrent Dermatophytosis (ISORD)

A Pilot Study to Assess The Therapeutic Effectiveness Of Isotretinoin In Preventing Recurrences In Chronic Recurrent Dermatophytosis

Sponsor: Post Graduate Institute of Medical Education and Research, Chandigarh

Conditions Tinea

Interventions Isotretinoin Itraconazole 200 mg Terbinafine

Updated 8 times since 2018 Last updated: Apr 30, 2018 Started: Apr 30, 2018 Primary completion: Jan 31, 2019 Completion: Jan 31, 2019

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT03471455, this PHASE2 trial focuses on Tinea and remains ongoing. Sponsored by Post Graduate Institute of Medical Education and Research, Chandigarh, it has been updated 8 times since 2018, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

8 versions recorded

Jul 2025 — Present [monthly]

Unknown PHASE2
Sep 2024 — Jul 2025 [monthly]

Unknown PHASE2
Jul 2024 — Sep 2024 [monthly]

Unknown PHASE2

Status: Unknown Status → Unknown
Apr 2024 — Jul 2024 [monthly]

Unknown Status PHASE2
Jan 2021 — Apr 2024 [monthly]

Unknown Status PHASE2

▶ Show 3 earlier versions

Apr 2020 — Jan 2021 [monthly]

Unknown Status PHASE2

Status: Not Yet Recruiting → Unknown Status
Jun 2018 — Apr 2020 [monthly]

Not Yet Recruiting PHASE2
Apr 2018 — Jun 2018 [monthly]

Not Yet Recruiting PHASE2

First recorded

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Post Graduate Institute of Medical Education and Research, Chandigarh

Data source: Post Graduate Institute of Medical Education and Research, Chandigarh

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

No location information available.